Skip to main content
OpenTrials
Completed

NCT Number: NCT02653885

Haematologic Predictors and Clinical Outcome in Cardiac Surgery

The outcome predictors for cardiac surgery has been popular for many researchers and clinicians. Determining risk factors before surgery reduce morbidity and mortality after surgery. Some routine blood results have been used as predictors for cardiac surgery but none of the researches studied red cell distribution width, mean platelet volume, platelet/lymphocyte ratio and neutrophil/lymphocyte ratio. This study focused on these parameters and to see whether these parameters can be predictors for cardiac surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Disease Cardiovascular Diseases Heart Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective, on-pump cardiac surgery

Exclusion criteria

  • emergent cases
  • pediatric cases
  • congenital surgery
  • heart transplantation

Treatment and study plan

Red red cell distribution width

Other

Results from hemogram

Other names: Mean platelet volume, Platelet/lymphocyte ratio, Neutrophil/lymphocyte ratio

Primary outcomes

  1. incidence of combined adverse effects

    Time frame: 48 hours

Sponsors and collaborators

Lead sponsor

Ankara University

Other

Registry information

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Jan 12, 2016
Registry last updated
Jan 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.